PetMed Express grants equity awards to interim CFO

KRULIK DOUGLAS reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

KRULIK DOUGLAS reported acquisition or exercise transactions in this Form 4 filing.

PETMED EXPRESS INC reported equity awards to CAO and Interim CFO Douglas Krulik effective June 26, 2026. He received 32,500 restricted common shares that vest 50% on June 26, 2027 and 50% on June 26, 2028, plus 32,500 performance share units tied to total shareholder return from April 1, 2026 to March 31, 2028.

The amended insider report corrects the PSUs’ performance period description and aligns their March 31, 2028 expiration date; it states no other changes. Following the restricted stock grant, Krulik directly holds 102,500 common shares.

Insider Trade Summary

Grant/Award: 65,000 shares

Grant/Award 2 txns

Insider KRULIK DOUGLAS

Role CAO and Interim CFO

Type	Security	Shares	Price	Value
Grant/Award	Performance Share Units F2	32,500	$0.00	$0.00
Grant/Award	Common Stock F1	32,500	$0.00	$0.00

Holdings After Transaction: Performance Share Units — 32,500 contracts (Direct); Common Stock — 102,500 shares (Direct)

Footnotes (2)

1. F1. Consists of a restricted stock award made pursuant to the PetMed Express, Inc. 2024 Omnibus Incentive Plan that vests as to 50% of granted shares on June 26, 2027, and 50% on June 26, 2028, subject to continued employment through each such vesting date.
2. F2. Performance Share Units ("PSUs") granted pursuant to the 2024 Omnibus Incentive Plan. Each PSU represents a contingent right to receive one share of the Company's Common Stock if predetermined levels of the Company's total shareholder return relative to the S&P 600 Specialty Retail Index are achieved over a two-year performance period beginning on April 1, 2026 ending on March 31, 2028.

Key Figures

Restricted stock grant: 32,500 shares Performance share units granted: 32,500 PSUs Common shares after grant: 102,500 shares +2 more

5 metrics

Restricted stock grant 32,500 shares Restricted common stock awarded to Douglas Krulik on June 26, 2026

Performance share units granted 32,500 PSUs PSUs contingent on TSR performance from April 1, 2026 to March 31, 2028

Common shares after grant 102,500 shares Direct common stock ownership by Douglas Krulik after restricted stock award

PSU expiration date March 31, 2028 Expiration date of performance share units granted under 2024 Omnibus Incentive Plan

Restricted stock vesting schedule 50% on June 26, 2027; 50% on June 26, 2028 Time-based vesting subject to continued employment through each vesting date

Key Terms

Performance Share Units, restricted stock award, total shareholder return, S&P 600 Specialty Retail Index, +1 more

5 terms

Performance Share Units financial

"Performance Share Units granted pursuant to the 2024 Omnibus Incentive Plan"

Performance share units are a type of company stock award given to employees that depend on the company meeting specific goals or targets. If these goals are achieved, the employee receives shares or the value of shares; if not, they may receive little or no compensation. This aligns employees’ interests with the company's success and encourages performance that benefits investors.

restricted stock award financial

"Consists of a restricted stock award made pursuant to the 2024 Omnibus Plan"

A restricted stock award is company shares given to an employee or executive that cannot be sold or fully owned until certain conditions—like staying with the company for a set time or hitting performance targets—are met. Think of it as a gift that only becomes yours after you fulfill specific obligations; for investors, these awards matter because they can increase the total shares outstanding when they vest, reveal how management is being paid and motivated, and create potential selling pressure when restrictions lift.

total shareholder return financial

"predetermined levels of the Company’s total shareholder return are achieved"

Total shareholder return is the overall gain an investor gets from owning a stock, combining changes in the share price plus any cash payouts like dividends, and assuming those payouts are reinvested in more shares. Investors use it like a single score that shows the true return on their investment—similar to checking both the growth of a savings account and the interest earned—to compare how well different companies or investments perform over time.

S&P 600 Specialty Retail Index financial

"relative to the S&P 600 Specialty Retail Index over a two-year period"

2024 Omnibus Incentive Plan financial

"awards made pursuant to the PetMed Express, Inc. 2024 Omnibus Incentive Plan"

FAQ

What equity awards did PETS executive Douglas Krulik receive on June 26, 2026?

Douglas Krulik received 32,500 restricted common shares and 32,500 performance share units on June 26, 2026. The awards were granted under PetMed Express’s 2024 Omnibus Incentive Plan as part of his compensation as CAO and Interim CFO.

How do the restricted stock awards to PETS executive Douglas Krulik vest?

The 32,500 restricted shares vest in two equal installments: 50% on June 26, 2027 and 50% on June 26, 2028. Vesting is conditioned on Krulik’s continued employment through each respective vesting date.

What are the performance goals for PETS performance share units granted to Douglas Krulik?

Each of the 32,500 performance share units represents a right to one common share if preset total shareholder return levels are achieved. Performance is measured relative to the S&P 600 Specialty Retail Index from April 1, 2026 to March 31, 2028.

What correction does this amended Form 4/A for PETS make?

The amendment corrects the performance period description for the PSUs and the related March 31, 2028 expiration date. It states that no other changes were made to the previously reported insider transactions.

How many PETS common shares does Douglas Krulik own after these grants?

After the June 26, 2026 restricted stock grant, Douglas Krulik directly owns 102,500 common shares of PetMed Express. This figure reflects his post-transaction direct ownership reported in the insider filing.

When do the PETS performance share units granted to Douglas Krulik expire?

The performance share units granted to Douglas Krulik have an expiration date of March 31, 2028. They cover a performance period from April 1, 2026 through March 31, 2028, tied to PetMed Express’s relative total shareholder return.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 07/24/2026 - 04:33 PM Accepted by SEC EDGAR 07/24/2026 - 04:32 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

KRULIK DOUGLAS

(Last) (First) (Middle)

C/O PETMED EXPRESS, INC.

420 SOUTH CONGRESS AVENUE

(Street)

DELRAY BEACH FLORIDA 33445

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
PETMED EXPRESS INC [ PETS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CAO and Interim CFO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/26/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)
06/26/2026

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/26/2026		A		32,500(1)	A	$0	102,500	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Performance Share Units	(2)	06/26/2026		A		32,500		(2)	03/31/2028	Common Stock	32,500	$0	32,500	D

Explanation of Responses:

1. Consists of a restricted stock award made pursuant to the PetMed Express, Inc. 2024 Omnibus Incentive Plan that vests as to 50% of granted shares on June 26, 2027, and 50% on June 26, 2028, subject to continued employment through each such vesting date.

2. Performance Share Units ("PSUs") granted pursuant to the 2024 Omnibus Incentive Plan. Each PSU represents a contingent right to receive one share of the Company's Common Stock if predetermined levels of the Company's total shareholder return relative to the S&P 600 Specialty Retail Index are achieved over a two-year performance period beginning on April 1, 2026 ending on March 31, 2028.

Remarks:

Explanatory Note: This Amended Form 4 is being filed solely to make a correction to the description of the performance period in Footnote 2 of the originally filed Form 4 filed on June 26, 2026, and to correspondingly revise the Expiration Date in Table II of the originally filed Form 4. No other changes were made to the originally filed Form 4.

	/s/ Douglas Krulik	06/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)